Giving patients access to cutting-edge treatmetns
Today the government announced a £340 million investment to offer patients earlier access to cutting-edge treatments, reducing waiting times, improving patient outcomes and tackling the Covid-19 backlogs.
- Early access to medicines and treatments can save lives while cutting waiting times, so it is vital that we offer these early interventions to as many patients as possible.
- That is why the government has announced an investment of £340 million through our Innovative Medicines Fund, which offers patients access to potentially transformative new drugs while further evidence is collected to inform on whether the treatment is clinically effective and a good use of taxpayer money in the long-term.
- The Innovative Medicines Fund delivers another manifesto pledge and will fast-track cutting-edge medicines to adults and children to give them renewed hope for a better future.
Comments